LRRC34 antibody
Principal name
LRRC34 antibody
Alternative names for LRRC34 antibody
Leucine-rich repeat-containing protein 34
Ncbi ID
9606, NP_001166250, NM_153353, NM_001172779, NM_027941, NM_001044696, NM_001172780
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of LRRC34 antibody
Transient overexpression lysate of leucine rich repeat containing 34 (LRRC34), transcript variant 2
Western blot analysis of LRRC34 Antibody (Center) Cat.-No AP52532PU-N in mouse heart tissue lysates (35ug/lane). This demonstrates the LRRC34 antibody detected the LRRC34 protein (arrow).
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AP52532PU-N | LRRC34 (Center) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu, Ms | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY407067 | LRRC34 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY433129 | LRRC34 overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR220486L2V | Lenti ORF particles, Lrrc34 (GFP-tagged) - Mouse leucine rich repeat containing 34 (Lrrc34), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR220486L1V | Lenti ORF particles, Lrrc34 (Myc-DDK-tagged) - Mouse leucine rich repeat containing 34 (Lrrc34), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR208975L2V | Lenti ORF particles, Lrrc34 (GFP-tagged ORF) - Rat similar to hypothetical protein MGC27085 (RGD1565052), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR208975L1V | Lenti ORF particles, Lrrc34 (Myc-DDK-tagged ORF) - Rat similar to hypothetical protein MGC27085 (RGD1565052), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
